Covid-19 Research

Review Article

Most Chronic Medical Conditions in Women are related to Increased Cellular Permeability and most can be Effectively Treated with Dopaminergic Drugs

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Review Article
Subject Medicine Group
OCLC JBRES Record
Jerome H Check*
Issue: Volume5-Issue4
Pages: 373-386
Received: 2024-04-16
Accepted: 2024-04-30
Published: 2024-04-30

Abstract

Based on a conglomeration of basic science research studies a model of hypothetical mechanisms of how the fetal semi-allograft can develop into a live baby was created. One of the tenets of the model is that it is necessary to remodel some of the typically thick-walled uterine arteries found during the proliferative phase into thin-walled spiral arteries to allow nutrient exchange between mother and fetus through an autoimmune mechanism during the luteal phase. The model suggests that the rise in progesterone inhibits dopamine. One function of dopamine is to diminish cellular permeability allowing irritants to infuse into the endometrium thus evoking an inflammatory reaction. The body must suppress these cellular immune cells from attacking the fetus. Progesterone activates membrane progesterone receptors which produces immunomodulatory proteins e.g., the Progesterone Induced Blocking Factor (PIBF), which negates the killing effect of cellular immunity. One hypothesis suggested that PIBF may be secreted by malignant tumors facilitating these tumors with foreign antigens to escape immunosurveillance and thus metastasize. Progesterone receptor antagonists e.g., mifepristone, which suppresses PIBF, have successfully increased length and quality of life in patients with a large variety of end stage treatment resistant cancers. Excessive permeability of various tissues was hypothesized to be related to possible relative deficiency of dopamine. A large variety of medical conditions have been ameliorated significantly by the use of dopaminergic drugs e.g. dextroamphetamine or cabergoline. The model explains why certain conditions may get worse premenstrually e.g., pelvic pain or headaches by the added suppressive effect of progesterone on dopamine. Though possibly further research may modify this model, based on the present hypothesis, a large number of treatment refractory conditions had very successful improvement based on treating with drug releasing dopamine thus correcting tissue permeability disorders.

FullText HTML FullText PDF DOI: 10.37871/jbres1903 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2024 Check JH. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Check JH. Most Chronic Medical Conditions in Women are related to Increased Cellular Permeability and most can be Effectively Treated with Dopaminergic Drugs. J Biomed Res Environ Sci. 2024 Apr 30; 5(4): 373-386. doi: 10.37871/jbres1903, Article ID: JBRES1903, Available at: https://www.jelsciences.com/articles/jbres1903.pdf

Subject area(s)

Womens Health and CarePharmacology

References

  1. Check JH, Childs TC, Brady LW, Derasse AR, Fuscaldo KE. Protection against spontaneous mouse mammary adenocarcinoma by inoculation of heat-treated syngeneic mammary tumor cells. Int J Cancer. 1971 May 15;7(3):403-8. doi: 10.1002/ijc.2910070305. PMID: 5559588.
  2. Check JH, Brady LW, Leipold PL, O'Neill EA. Protection against transplanted and spontaneous lymphoma by inoculation of heat-altered syngeneic tumor cells in splenectomized mice. Cancer. 1974 Jul;34(1):197-203. doi: 10.1002/1097-0142(197407)34:1<197::aid-cncr2820340130>3.0.co;2-r. PMID: 4834179.
  3. Check JH, Brady LW, O'Neill EA. Differences in the protective effect of complete Freund's adjuvant in spontaneous versus transplanted lymphomas in AKR mice. Prog Exp Tumor Res. 1974;19:217-21. doi: 10.1159/000395858. PMID: 4438641.
  4. Check JH, Silverman GA, Dryden RL, Brady LW. Inhibition of spontaneous AKR leukemia by multiple inoculations of Corynebacterium parvum. Cancer. 1979 Aug;44(2):488-91. doi: 10.1002/1097-0142(197908)44:2<488::aid-cncr2820440218>3.0.co;2-h. PMID: 476565.
  5. Check JH, Nazari P, Goldberg J, Yuen W, Angotti D. A model for potential tumor immunotherapy based on knowledge of immune mechanisms responsible for spontaneous abortion. Med Hypotheses. 2001 Sep;57(3):337-43. doi: 10.1054/mehy.2001.1333. PMID: 11516226.
  6. Check JH, Aly J, Chang E. Improving the chance of successful implantation - part I - embryo attachment to the endometrium and adequate trophoblast invasion. Clin Exp Obstet Gynecol. 2016;43(6):787-791. PMID: 29944223.
  7. Check DL, Check JH. Novel methods of improving fecundity and various pathological disorders based on hypothetical model of embryo implantation. Gynecol Reprod Health. 2020;4(4):1-15. doi :10.33425/2639-9342.1139.
  8. Check JH, Szekeres-Bartho J, O'Shaughnessy A. Progesterone induced blocking factor seen in pregnancy lymphocytes soon after implantation. Am J Reprod Immunol. 1996 Mar;35(3):277-80. doi: 10.1111/j.1600-0897.1996.tb00045.x. PMID: 8962661.
  9. Check JH, Arwitz M, Gross J, Szekeres-Bartho J, Wu CH. Evidence that the expression of progesterone-induced blocking factor by maternal T-lymphocytes is positively correlated with conception. Am J Reprod Immunol. 1997 Jul;38(1):6-8. doi: 10.1111/j.1600-0897.1997.tb00269.x. PMID: 9266004.
  10. Check JH, Aly J. Improving the chance of successful implantation -part 2 -circumventing immune rejection and the fetal semi-allograft. Clin Exp Obstet Gynecol. 2018;45(1):9-13. doi: 10.12891/ceog4381.2018.
  11. Check JH, Liss J, Check D. The beneficial effect of luteal phase support on pregnancy rates in women with unexplained infertility. Clin Exp Obstet Gynecol. 2019;46(3):447-9. doi: 10.12891/ceog4697.2019.
  12. Check JH. Pros and cons of the use of progesterone to reduce miscarriage rates. Clin Exp Obstet Gynecol. 2018; 45(5):652-5. doi: 10.12891/ceog4693.2018.
  13. Cohen RA, Check JH, Dougherty MP. Evidence that exposure to progesterone alone is a sufficient stimulus to cause a precipitous rise in the immunomodulatory protein the progesterone induced blocking factor (PIBF). J Assist Reprod Genet. 2016 Feb;33(2):221-9. doi: 10.1007/s10815-015-0619-7. Epub 2015 Dec 3. PMID: 26634256; PMCID: PMC4759003.
  14. Check JH, Lee G. Check JH, Lee G. Untreated luteal phase deficiency as another possible risk factor for preterm delivery. Am J Obstet Gynecol. 1991 Aug;165(2):485-6. doi: 10.1016/0002-9378(91)90127-d. PMID: 1872363.
  15. Check JH, Dix E, Sansoucie L. Support for the hypothesis that successful immunotherapy of various cancers can be achieved by inhibiting a progesterone associated immunomodulatory protein. Med Hypotheses. 2009 Jan;72(1):87-90. doi: 10.1016/j.mehy.2008.05.042. Epub 2008 Oct 7. PMID: 18842348.
  16. Check JH, Cohen R. The role of progesterone and the progesterone receptor in human reproduction and cancer. Expert Rev Endocrinol Metab. 2013 Sep;8(5):469-484. doi: 10.1586/17446651.2013.827380. PMID: 30754194.
  17. Check JH, Check D. Therapy Aimed to Suppress the Production of the Immunosuppressive Protein Progesterone Induced Blocking Factor (PIBF) May Provide Palliation and/or Increased Longevity for Patients With a Variety of Different Advanced Cancers - A Review. Anticancer Res. 2019 Jul;39(7):3365-3372. doi: 10.21873/anticanres.13479. PMID: 31262857.
  18. Check JH, Check DL. A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation. Int J Mol Sci. 2021 Nov 16;22(22):12351. doi: 10.3390/ijms222212351. PMID: 34830233; PMCID: PMC8621132.
  19. Check JH, Check DL. The role of progesterone and the progesterone receptor in cancer: progress in the last 5 years. Expert Rev Endocrinol Metab. 2023 Jan;18(1):5-18. doi: 10.1080/17446651.2023.2166487. Epub 2023 Jan 16. PMID: 36647582.
  20. Check JH, Dix E, Sansoucie L, Check D. Mifepristone may halt progression of extensively metastatic human adenocarcinoma of the colon - case report. Anticancer Res. 2009 May;29(5):1611-3. PMID: 19443374.
  21. Check JH, Dix E, Cohen R, Check D, Wilson C. Efficacy of the progesterone receptor antagonist mifepristone for palliative therapy of patients with a variety of advanced cancer types. Anticancer Res. 2010 Feb;30(2):623-8. PMID: 20332480.
  22. Check JH, Wilson C, Cohen R, Sarumi M. Evidence that Mifepristone, a progesterone receptor antagonist, can cross the blood brain barrier and provide palliative benefits for glioblastoma multiforme grade IV. Anticancer Res. 2014 May;34(5):2385-8. PMID: 24778047.
  23. Check JH, Check D, Wilson C, Lofberg P. Long-term High-quality Survival with Single-agent Mifepristone Treatment Despite Advanced Cancer. Anticancer Res. 2016 Dec;36(12):6511-6513. doi: 10.21873/anticanres.11251. PMID: 27919975.
  24. Check JH, Check DL, Dougherty MP. Progesterone receptor antagonists -a novel treatment for severe hyponatremia from the endocrine paraneoplastic syndrome. J Endocrinol Res. 2021;3(2):40-3. doi: 10.30564/jer.v3i2.3611.
  25. Check JH, Check D, Poretta T. Mifepristone Extends Both Length and Quality of Life in a Patient With Advanced Non-small Cell Lung Cancer that Has Progressed Despite Chemotherapy and a Check-point Inhibitor. Anticancer Res. 2019 Apr;39(4):1923-1926. doi: 10.21873/anticanres.13301. PMID: 30952734.
  26. Check DL, Check JH. Significant palliative benefits of single agent mifepristone for advanced lung cancer that previously failed standard therapy. Med Clin Sci. 2019;1(2):1-5. doi: 10.33425/2690-5191.1011.
  27. Check DL, Check JH, Poretta T, Aikens J, Wilson C. Prolonged high-quality life in patients with non-small cell lung cancer treated with mifepristone who advanced despite osimertinib. Cancer Sci Res. 2020;3(3):1-5.
  28. Check DL, Check JH, Poretta T. Conservative laparoscopic surgery plus mifepristone for treating multifocal renal cell carcinoma. Cancer Sci Res. 2020;3(3)1-4.
  29. Check JH, Check D, Srivastava MD, Poretta T, Aikins JK. Treatment With Mifepristone Allows a Patient With End-stage Pancreatic Cancer in Hospice on a Morphine Drip to Restore a Decent Quality of Life. Anticancer Res. 2020 Dec;40(12):6997-7001. doi: 10.21873/anticanres.14724. Epub 2020 Dec 7. PMID: 33288594.
  30. Check JH, Check D, Poretta T, Wilson C. Palliative Benefits of Oral Mifepristone for the Treatment of Metastatic Fibroblastic Osteosarcoma. Anticancer Res. 2021 Apr;41(4):2111-2115. doi: 10.21873/anticanres.14982. PMID: 33813421.
  31. Check JH, Check DL, DO TP, Srivastava M, Check E. Significant Palliative Benefits Following Therapy With Mifepristone for Advanced Treatment Resistant Small Cell Lung Cancer. Anticancer Res. 2024 Feb;44(2):659-664. doi: 10.21873/anticanres.16855. PMID: 38307551.
  32. Check JH, Cohen R. The role of progesterone and the progesterone receptor in human reproduction and cancer. Expert Rev Endocrinol Metab. 2013 Sep;8(5):469-484. doi: 10.1586/17446651.2013.827380. PMID: 30754194.
  33. Check JH, Poretta T, Check D, Srivastava M. Lung Cancer - Standard Therapy and the Use of a Novel, Highly Effective, Well Tolerated, Treatment With Progesterone Receptor Modulators. Anticancer Res. 2023 Mar;43(3):951-965. doi: 10.21873/anticanres.16240. PMID: 36854512.
  34. Check JH, Check D, Neumann B. Future directions to explore to develop ideal anti-cancer progesterone receptor modulators. Cancer Sci Res. 2023;6(1):1-8.
  35. Check JH, Check D. New Insights as to Why Progesterone Receptor Modulators, such as Mifepristone, Seem to Be More Effective in Treating Cancers that Are Devoid of the Classical Nuclear Progesterone Receptor. Anticancer Res. 2021 Dec;41(12):5873-5880. doi: 10.21873/anticanres.15407. PMID: 34848442.
  36. Check D, Check JH, Wilson C. Alpelisib combined with low dose mifepristone for treating advanced breast cancer may cause hypokalemia even when this complication does not occur from single use of the anticancer agents. Cancer Sci Res. 2020;3(3):1-4. doi :10.33425/2639-8478.1057
  37. Check JH, Gentlesk MJ, Falanga V. Sympathomimetic amines in the treatment of chronic urticaria: two case reports. Cutis. 1984 Oct;34(4):388-90. PMID: 6488891.
  38. Check JH, Wilson C. Dramatic relief of chronic pelvic pain with treatment with sympathomimetic amines--case report. Clin Exp Obstet Gynecol. 2007;34(1):55-6. PMID: 17447641.
  39. Check JH, Cohen R. The triad of luteal phase ocular migraines, interstitial cystitis, and dyspareunia as a result of sympathetic nervous system hypofunction. Clin Exp Obstet Gynecol. 2014;41(5):575-7. PMID: 25864263.
  40. Check JH, Cohen R. Marked improvement of vulvovaginitis of unknown origin in a pediatric patient--case report. Clin Exp Obstet Gynecol. 2014;41(6):723-4. PMID: 25551972.
  41. Check JH, Jaffe A. Resolution of pelvic pain related to adenomyosis following treatment with dextroamphetamine sulfate. Clin Exp Obstet Gynecol. 2015;42(5):671-2. PMID: 26524821.
  42. Check JH. Increased tissue permeability and sympathetic nervous system hypofunction may be the common link between dysmenorrhea, chronic pelvic pain, Mittelschmerz, and Crohn's disease. Clin Exp Obstet Gynecol. 2016;43(1):112-3. PMID: 27048029.
  43. Check JH, Katsoff B, Citerone T, Bonnes E. A novel highly effective treatment of interstitial cystitis causing chronic pelvic pain of bladder origin: case reports. Clin Exp Obstet Gynecol. 2005;32(4):247-9. PMID: 16440825.
  44. Check J, Dix E, Check D, Summers-Chase D, Horwath D. Pregnancy rates following frozen embryo transfer (ET) in women failing to conceive despite fresh ET in women using low dosage follicle stimulating hormone (FSH) protocol for follicular maturation of several eggs. Clin Exp Obstet Gynecol. 2012;39(2):139-40. PMID: 22905449.
  45. Check JH, Cohen R. Chronic pelvic pain--traditional and novel therapies: part II medical therapy. Clin Exp Obstet Gynecol. 2011;38(2):113-8. PMID: 21793268.
  46. Check JH, Chern R, Katsoff B. Prevention of first-trimester miscarriage with dextroamphetamine sulfate treatment in women with recurrent miscarriage following embryo transfer -- case report. Clin Exp Obstet Gynecol. 2013;40(4):471-2. PMID: 24597235.
  47. Check JH: A Follicle Stimulating Hormone (FSH) receptor up-regulation technique as a method for follicular recruitment for in vitro fertilization in women with diminished oocyte to review. Leon V. Berhardt editors. In: Advances in Medicine and Biology, Nova Science Publishers, Inc., Hauppauge, New York: 2022. p.119-137.
  48. Check JH, Choe JK. Maximizing correction of infertility with moderate to marked diminished egg reserve in natural cycles by up-regulating follicle stimulating hormone receptors. Gynecol Reprod Health. 2022;6(4):1-7. doi :10.33425/2639-9342.1197.
  49. Nowroozi K, Chase JS, Check JH, Wu CH. The importance of laparoscopic coagulation of mild endometriosis in infertile women. Int J Fertil. 1987 Nov-Dec;32(6):442-4. PMID: 2891631.
  50. Check JH. What role does decreased ovarian reserve play in the aetiology of infertility related to endometriosis? Hum Reprod. 2003 Mar;18(3):653-4; author reply 654-5. doi: 10.1093/humrep/deg086. PMID: 12615841.
  51. Check JH, Liss JR, Krotec JW, Choe JK, Brasile D. The effect of endometriosis on pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women with decreased egg reserve. Clin Exp Obstet Gynecol. 2010;37(2):108-9. PMID: 21077497.
  52. Check JH. The association of minimal and mild endometriosis without adhesions and infertility with therapeutic strategies. Clin Exp Obstet Gynecol. 2003;30(1):13-8. PMID: 12731736.
  53. Check JH. Chronic pelvic pain syndromes--traditional and novel therapies: part I surgical therapy. Clin Exp Obstet Gynecol. 2011;38(1):10-3. PMID: 21485716.
  54. Check JH, Check D. Improvement of severe chronic pelvic pain and dysmenorrhea following treatment with cabergoline. Gyn and Reprod Health. 2023;7(1):1-6.
  55. Check JH, Neumann B, Check D. New insight into the etiology and treatment of the vulvostomatodynia syndrome and review of treating pelvic pain of all types with dopaminergic drugs. Gyn and Reprod Health.
  56. Check JH, Dougherty MP. Use of sympathomimetic amines to correct premenstrual urticaria and anaphylaxis. Clin Exo Obstet Gynecol. 2019;46(2):309-12. doi : 10.12891/ceog4727.2019.
  57. Check JH, Check D, Cohen R. Sympathomimetic amine therapy may markedly improve treatment resistant headaches related to a vascular permeability defect common in women--presentation of two cases. Clin Exp Obstet Gynecol. 2009;36(3):189-91. PMID: 19860368.
  58. Check JH, Cohen R, Check D. Evidence that migraine headaches in women may be related to a common defect in the sympathetic nervous system as evidenced by marked improvement following treatment with sympathomimetic amines. Clin Exp Obstet Gynecol. 2011;38(2):180-1. PMID: 21793286.
  59. Check JH, DiAntonio G, Cohen R. Dextroamphetamine sulfate, a very effective drug for pelvic pain relieved severe retroorbital stabbing pain in a woman with keratoconus who failed to respond to bilateral corneal implants. Clin Exp Obstet Gynecol. 2014;41(1):80-2. PMID: 24707691.
  60. Check JH, Cohen R. Severe headaches from intracranial hypertension (pseudotumor cerebri) abrogated by treatment with dextroamphetamine sulfate. Clin Exp Obstet Gynecol. 2014;41(2):211-3. PMID: 24779255.
  61. Check JH. Dextroamphetamine sulfate treatment eradicates long-term chronic severe headaches from temporomandibular joint syndrome--a case that emphasizes the role of the gynecologist in treating headaches in women. Clin Exp Obstet Gynecol. 2016;43(1):119-22. PMID: 27048031.
  62. Check JH, Citerone T. The increased cellular permeability syndrome as a cause of traumatic stuttering. Clin Exp Obstet Gynecol. 2018;45(5):773-4. doi: 10.12891/ceog4694.2018.
  63. Check DL, Check JH. Various presentations of the increased cellular permeability syndrome in males responding very well to sympathomimetic amine therapy –possible treatment for end- stage Covid-19 complications. J Med Clin Res&Rev. 2020;4(7):1-7 doi :10.33425/2639-944X.1153.
  64. Check JH, Katsoff B. Transient sixth cranial nerve palsy following orgasm abrogated by treatment with sympathomimetic amines. Clin Exp Obstet Gynecol. 2014;41(4):468-70. PMID: 25134302.
  65. Check JH. Sympathetic neural hyperalgesia edema syndrome as a cause of autoimmune hearing loss. Clin Exp Obstet Gynecol. 2017;44(1):133-134. PMID: 29714882.
  66. Check JH, Check D, Cohen R. A novel effective treatment for meniere’s disease - dextroamphetamine sulfate. Clin Exp Obstet Gynecol.2020;47:807-9. doi: 10.31083/j.ceog.2020.05.5238.
  67. Present SI, Check JH. Hypofunction of the Sympathetic Nervous System as a Possible Etiologic Cause of Recurrent Aphthous Stomatitis. Compend Contin Educ Dent. 2016 Jun;37(6):381-385;quiz386. PMID: 27517475.
  68. Check JH, Katsoff D, Kaplan H, Liss J, Boimel P. A disorder of sympathomimetic amines leading to increased vascular permeability may be the etiologic factor in various treatment refractory health problems in women. Med Hypotheses. 2008;70(3):671-7. doi: 10.1016/j.mehy.2007.05.052. Epub 2007 Aug 31. PMID: 17765403.
  69. Check JH, Check D, Liss JR. Effect of treatment with dextroamphetamine sulfate on weight loss up to 5 years in women unable to lose weight by dieting and its efficacy on some other unusual manifestations of the increased cellular permeability syndrome. J Med Clin Res&Rev. 2021;5:1-5.
  70. Check JH. Chronic unremitting lower abdominal pain quickly abrogated following treatment with amphetamine. Clin Exp Obstet Gynecol. 2016;43(1):109-11. PMID: 27048028.
  71. Check JH, Katsoff B. The use of sympathomimetic amines for the treatment of severe constipation refractory to conventional therapy--case report. Clin Exp Obstet Gynecol. 2013;40(2):284-5. PMID: 23971260.
  72. Check JH, Neumann B. Correction of treatment refractory infertility and severe constipation following treatment with supplemental progesterone and a dopaminergic drug. Gynecol Reprod Health. 2024
  73. Check JH, Cohen R. Successful treatment of a female with chronic pseudo-intestinal obstruction with sympathomimetic amines and thyroid hormone replacement. Clin Exp Obstet Gynecol. 2010;37(2):115-6. PMID: 21077500.
  74. Boimel P, Check JH, Katsoff D. Sympathomimetic amine therapy may improve refractory gastroparesis similar to its effect on chronic pelvic pain –case report. Clin Exp Obstet Gynecol. 2007;34:185-7.
  75. Check JH, Cohen R. Marked improvement of severe gastroparesis following high dosage, but very well tolerated, dextroamphetamine sulfate. Clin Exp Obstet Gynecol. 2017;44:611-2.
  76. Check JH, Cohen R, Katsoff B, Check D. Hypofunction of the sympathetic nervous system is an etiologic factor for a wide variety of chronic treatment-refractory pathologic disorders which all respond to therapy with sympathomimetic amines. Med Hypotheses. 2011 Nov;77(5):717-25. doi: 10.1016/j.mehy.2011.07.024. Epub 2011 Aug 10. PMID: 21835553.
  77. Check JH, Cohen R. Sympathomimetic amine therapy abrogates severe long-term unexplained abdominal pain and diarrhea (microscopic colitis) -possible infertility implications. Clin Exp Obstet Gynecol. 2019;46:489-91.
  78. Check JH, Katsoff B, Cohen R. Novel highly effective medical treatment of severe treatment refractory Crohn's disease using sympathomimetic amines: case report. Inflamm Bowel Dis. 2010 Dec;16(12):1999-2000. doi: 10.1002/ibd.21269. PMID: 20848483.
  79. Katsoff B, Check JH. Successful pregnancy in a 45-year-old woman with elevated day 3 serum follicle stimulating hormone and a short follicular phase. Clin Exp Obstet Gynecol. 2005;32(2):97-8. PMID: 16108390.
  80. Check JH, Katsoff B, Cohen R. Case report showing that a woman with ulcerative colitis refractory to standard therapy responded well to the sympathomimetic amine dextroamphetamine sulfate. Inflamm Bowel Dis. 2011 Mar;17(3):870-1. doi: 10.1002/ibd.21387. PMID: 20602469.
  81. Check JH, Neumann B. Combined dopaminergic drugs with supplemental progesterone to treat recurrent miscarriage and ulcerative colitis despite diminished egg reserve. Gynecol Reprod Health. 2024..
  82. Check JH, Neumann B, Check DL. Dopaminergic drugs to relieve pain from chronic pancreatitis –a novel therapy. J Med Clin Res Rev. 2024;8(1):1-4.
  83. Check JH, Shanis BS, Shapse D, Adelson HG. A randomized comparison of the effect of two diuretics, a converting enzyme inhibitor, and a sympathomimetic amine on weight loss in diet-refractory patients. Endocr Pract. 1995 Sep-Oct;1(5):323-6. doi: 10.4158/EP.1.5.323. PMID: 15251577.
  84. Check JH, Cohen G, Cohen R, Dipietro J, Steinberg B. Sympathomimetic amines effectively control pain for interstitial cystitis that had not responded to other therapies. Clin Exp Obstet Gynecol. 2013;40(2):227-8. PMID: 23971244.
  85. Check JH, Check D. The increased cellular permeability syndrome manifesting as severe idiopathic type urinary incontinence. Clin Exp Obstet Gynecol. 2019;46(5):812-4. doi:10.12891/ceog5179.2019.
  86. Check JH, Amadi C, Kaplan H, Katsoff D. The treatment of idiopathic edema, a cause of chronic pelvic pain in women: effectively controlled chronic refractory urticaria--case reports. Clin Exp Obstet Gynecol. 2006;33(3):183-4. PMID: 17089586.
  87. Check JH, Cohen R, Check D. Idiopathic edema, a condition associated with pelvic pain and other symptoms in women, as a remedial cause of chronic cold induced urticaria. Clin Exp Obstet Gynecol. 2010;37(3):235-6. PMID: 21077535.
  88. Check JH, Chan S. Complete eradication of chronic long standing eczema and keratosis pilaris following treatment with dextroamphetamine sulfate. Clin Exp Obstet Gynecol. 2014;41(2):202-4. PMID: 24779252.
  89. Check JH, Cohen R. Amelioration of severe generalized idiopathic pruritus in an estrogen deficient woman taking an aromatase inhibitor for breast cancer following treatment with amphetamine salts. Clin Exp Obstet Gynecol. 2017;44(6):934-5. doi: 10.12891/ceog4380.2017.
  90. Check JH, Lombardi G, Neumann B, Check DL. The use of dopaminergic drugs for treating cutaneous discoid lupus of bullous pemphigoid. J Med Clin Res Rev. 2024.
  91. Boimel P, Check JH. Marked improvement of intractable arthritic pain in a woman with rheumatoid arthritis with sympathomimetic amine treatment despite previous failure with standard therapy and possible implications for last trimester unexplained fetal demise--case report. Clin Exp Obstet Gynecol. 2007;34(4):254-6. PMID: 18225693.
  92. Check JH, Cohen R. Sympathetic neural hyperalgesia edema syndrome, a frequent cause of pelvic pain in women, mistaken for Lyme disease with chronic fatigue. Clin Exp Obstet Gynecol. 2011;38(4):412-3. PMID: 22268288.
  93. Check DL, Check JH, Citerone T, Cremin N. Sympathomimetic amine therapy markedly improves severe fatigue that diminishes quality of life in patients with cancer –a case report. Cancer Sci Res. 2020;3(3):1-3.
  94. Weidner J, Check JH. Marked improvement of the autoimmune syndrome associated with autoimmune hepatitis by treatment with sympathomimetic amines. Clin Exp Obstet Gynecol. 2014;41(4):460-1. PMID: 25134299.
  95. Check JH, Cohen R. Marked improvement of pain from long-term fibromyalgia with dextroamphetamine sulfate in a woman who failed to improve with conventional pharmacologic treatment. Clin Exp Obstet Gynecol. 2014;41(1):90-2. PMID: 24707694.
  96. Check JH, Cohen R. Complete resolution of frozen shoulder syndrome in a woman treated with dextroamphetamine sulfate for chronic urinary urgency. Clin Exp Obstet Gynecol. 2015;42(5):679-80. PMID: 26524823.
  97. Check JH, Check DL, Dougherty MP. Marked improvement of the aromatase induced arthralgia syndrome following treatment with dextroamphetamine sulfate. Clin Exp Obstet Gynecol. 2019; 46: 291-2. doi: 10.12891/ceog4707.2019.
  98. Check JH, Whetstone A. Failed surgical therapy for chronic back pain and sciatica may be due to hypofunction of the sympathetic nervous system. Clin Exp Obstet Gynecol. 2015;42(4):529-30. PMID: 26411226.
  99. Check JH, Wilson C, Cohen R. Sympathetic nervous system disorder of women that leads to pelvic pain and symptoms of interstitial cystitis may be the cause of severe backache and be very responsive to medical therapy rather than surgery despite the presence of herniated discs. Clin Exp Obstet Gynecol. 2011;38(2):175-6. PMID: 21793284.
  100. Potestio CP, Check JH, Mitchell-Williams J. Improvement in symptoms of the syndrome of mitochondrial encephalopathy, lactic acidosis, and stroke-like symptoms (MELAS) following treatment with sympathomimetic amines--possible implications for improving fecundity in women of advanced reproductive age. Clin Exp Obstet Gynecol. 2014;41(3):343-5. PMID: 24992791.
  101. Check JH, Neumann B, Check DL, Lombardi G. Dopaminergic drugs for the successful treatment of bullous pemphigoid. J Med Clin Res Rev. 2024.
  102. Check JH, Dougherty MP, Check DL. Long standing post-herpetic neuralgia resistant to standard anti-neuropathy medication showing quick improvement following treatment with sympathomimetic amines. Clin Exp Obstet Gynecol. 2019;46(2):335-6. doi: 10.12891/ceog4706.2019.
  103. Check DL, Check JH, Katsoff B. Dextroamphetamine sulfate therapy markedly improves the chronic fatigue syndrome. J Nurs Occup Health. 2020;2(3):146-8.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership